Milson Yu

Milson represents private and public companies and investment banks in various capital markets and corporate transactions, including initial public offerings, follow-on and secondary offerings, debt offerings and SPAC mergers. Milson also counsels public companies on a full range of corporate and securities matters, including SEC reporting obligations and corporate governance.

Milson’s recent representative transactions include advising:

• Navan on its $923 million initial public offering (IPO)
• Ethos on its $200 million IPO
• Instacart on its $660 million IPO
• Confluent on its $828 million IPO and its $1.1 billion Rule 144A convertible notes offering
• 1Life Healthcare (One Medical) on its:
  • $281.8 million IPO
  • $275 million Rule 144A convertible notes offering
  • $2.1 billion all-stock acquisition of Iora Health
• Thayer Ventures on its $1.1 billion deSPAC business combination with Inspirato
• Opthea on its $128 million IPO
• Docebo on its $165.6 million IPO and multiple secondary offerings
• Absolute Software on its $69 million IPO and its $340 million cash acquisition of NetMotion
• The underwriters on AssetMark’s $316 million IPO
• NVIDIA on registered notes offerings raising $10 billion in aggregate
• Jazz Pharmaceuticals on its $1 billion Rule 144A exchangeable notes offering